沈世强，男，1957年5月生，籍贯湖北。1994年毕业于日本名古屋大学，医学博士。教授、主任医师。现任外科副主任、普外科主任，博士生导师。主要从事肝胆胰外科临床与实验研究，曾获湖北省科技进步三等奖、武汉市科技进步二等奖，主编专著一部、参编五部，在国内外杂志上发表论文百篇余。已培养博士生十余名、硕士生二十余名；目前正在培养的博士生（含在职）十余名、硕士生４名。

主要研究方向：

1. 肝癌外科分子生物学

2. 肝脏保护

学术职务：

中国医师协会外科医师分会委员

武汉医学会普通外科学会副主委

湖北省医学会普通外科学会常务委员

武汉抗癌研究会会长

腹部外科杂志副主编

临床外科杂志常务编委

中华实验外科杂志编委

世界胃肠杂志编委

国际外科学杂志编委

中国医药导报杂志编委

World Journal of Gastroenterology 编委

中华医学杂志英文版及Journal of Surgical Oncology等杂志审稿专家

教育履历：

1978.03－1982.12 湖北医学院临床医学系本科生

1986.09－1987.09 湖北医学院外科硕士研究生

1987.10－1994.03 日本名古屋大学医学部外科博士及博士后

工作履历：

1983.02－1986.08 武汉市第四医院住院医师 

1994.04－现在 武汉大学人民医院普外科医师

成果获奖： 

“肝癌射频热疗的实验和临床应用研究”获湖北省科技进步三等奖，武汉市科技进步二等奖，项目第一完成人。

论文代表作：

1. The Protective Effects of 17β-Estradiol on Hepatic Ischemia-Reperfusion Injury in Rat Model, Associated with Regulation of Heat-Shock Protein Expression. J Surg Res. 2007, 140：67-76

2. Protective effct of Curcumin against Liver Warm Ischemia-Reperfusion Injury in Rat Model, associated with Regulation of Heat Shock Protein and Antioxidant Enzymes. World J Gastroenterol. 2007, 13(13):1953-1961.

3. Expression and Clinical significance of NET-1 and PCNA in Hepatocellular carcinoma.Med Oncol.2008,25（3）:341-345.

4. Microvessel damage may play a main role in tumoricidal effect for murine H22 hepatoma cells with hyperthermia in vivo. J Surg Res. 2008,145:97-104.

5. Intraoperative radiofrequency thermal ablation combined with portal vein infusion Chemotherapy and transarterial chemoembolization for unresectable HCC. Hepatogastroenterology. 2005, 52(65): 1403-1407.

6. The angimogenic and prognostic implications of VEGF,Ang-1.Ang-2,and MMP-9 for hepatocellular carcinoma with background of hepatitis B virus MEDICAL INCOLOGY,2009，26（3）：365-371.

7. Intratumoural GM-CSF microspheres and CTLA-4 blockade enhance the antiumour immunity induced by thermal ablation in a subcutaneous mutine hepatoma model.INTERNATIONAL JOURNAL OF HYPERTHERMIA，2009,25(5):374-382.

8. The role of prophyloetic antibiotics in laparoscopic cholecystectomy in preventing postoperatine infection a meta-analysis.　Adv   Surg Tech. 2011, 24(4):301-306．

9. Expression of augmenter of liver regeneration and nuclear faction-kb in human hepatocelluar carcinoma .J Anio Veto Adro .2011,10（4）：440-448．

10.17β-estradiol attenuates reduced-sige hepatic ischemia/heperfusion injury by inhibition apoptosis via mitochodrial in rats.Shock,2012,37(2):183-190． 

11. Growth inhibition of hepatocellular carcinoma tumor endothelial cells by miR-204-3p and underlying mechanism. World J Gastroenterol， 2014，20（18）：5493－5504.

12. The liver protective effect of methylprednisolone on a new experimental acute-on-chronic liver failure model in rats. Digestive and Liver Disease, 2014, 46(10):928-935. 

13. Regulation of tumorigenesis and metastasis of hepatocellular carcinoma tumor endothelial cells by microRNA-3178 and underlying mechanism. Biochem Biophys Res Commun.2015,464(3):881-887.

14. simultaneous hepatectomy and splenectomy versus hepatectomy alone for hepatocellular carcinoma complicated by hypersplenism a meta-analysis. Onco Targets Ther. 2015, 8:2129-37.

15. Effect of microRNA-1 on hepatocellular carcinoma tumor endothelial cells. World J Gastroenterol. 2015, 21(19):5884-92.